ArticleScientific reports2025

Cell therapy with placenta-derived mesenchymal stem cells for secondary progressive multiple sclerosis patients in a phase 1 clinical trial.

Ameneh Shokati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.